ALKT Stock Cash Flow Statements

Alkami Technology . Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Alkami Technology . Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31

cash flows from operating activities:
net income	-13,591,000	-7,816,000	-9,442,000	-12,317,000	-11,433,000	-12,713,000	-15,476,000	-17,761,000	-16,963,000	-4,912,000	-20,049,000	-20,233,000	-13,406,000	-13,349,000	-11,219,000	-11,375,000	-10,879,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization expense	7,756,000	3,430,000	2,679,000	2,613,000	2,562,000	2,790,000	2,695,000	2,560,000	2,586,000	2,563,000	2,550,000	1,944,000	1,018,000	1,059,000	802,000	796,000	786,000
accrued interest on marketable securities	-261,000	-279,000	-141,000	-493,000	-294,000	-1,172,000	-880,000	-781,000	-398,000	-302,000	-31,000	6,000	-42,000
stock-based compensation expense	19,515,000	16,093,000	15,257,000	15,013,000	13,552,000	13,317,000	13,515,000	12,959,000	11,440,000	11,799,000	12,147,000	11,475,000	9,974,000	6,742,000	3,352,000	3,023,000	1,418,000
amortization of discount and debt issuance costs	593,000	192,000
loss on impairment of intangible assets	0	1,655,000
deferred taxes	-3,694,000	-8,312,000	14,000	22,000	25,000	-150,000	33,000	38,000	47,000	-610,000	-242,000	128,000	34,000
changes in operating assets and liabilities:
accounts receivable	-889,000	-6,572,000	-3,456,000	-3,235,000	-218,000	-4,233,000	-3,114,000	277,000	-2,183,000	-325,000	1,069,000	-2,228,000	-2,529,000	-540,000	-4,254,000	-975,000	-512,000
prepaid expenses and other assets
accounts payable and accrued liabilities	6,201,000	-2,002,000	6,969,000	3,220,000	-3,873,000	-5,132,000	7,349,000	-836,000	-1,290,000	-4,964,000	1,941,000	1,234,000	415,000	-5,933,000	4,907,000	469,000	7,382,000
deferred costs	-2,122,000	-158,000	-2,498,000	-1,258,000	-1,311,000
deferred revenues	-2,015,000	3,521,000	338,000	-1,005,000	3,654,000	2,358,000	1,456,000	-1,009,000	824,000	469,000	-187,000	624,000	-384,000	1,945,000	-20,000	-914,000	35,000
net cash from operating activities	1,157,000	-5,664,000	10,987,000	548,000	951,000	-5,305,000	3,128,000	-5,710,000	-9,615,000	-13,743,000	-4,676,000	-11,078,000	-8,291,000	-12,157,000	-4,514,000	-10,336,000	-1,952,000
capex	-2,159,000	-1,931,000	-2,299,000	-2,077,000	-1,669,000	-284,000	-1,539,000	-1,708,000	-1,370,000	-960,000	-786,000	-1,414,000	-1,542,000	-1,552,000	-1,025,000	-696,000	-424,000
free cash flows	-1,002,000	-7,595,000	8,688,000	-1,529,000	-718,000	-5,589,000	1,589,000	-7,418,000	-10,985,000	-14,703,000	-5,462,000	-12,492,000	-9,833,000	-13,709,000	-5,539,000	-11,032,000	-2,376,000
cash flows from investing activities:
purchase of marketable securities	-8,088,000	-21,883,000	-15,133,000	-8,439,000	-7,149,000	-31,223,000	-46,953,000	-41,653,000	-20,987,000	-23,124,000	-20,504,000	-31,510,000	-112,079,000
proceeds from sales, maturities and redemptions of marketable securities	7,300,000	9,900,000	21,203,000	25,983,000	15,626,000
purchases of property and equipment	-397,000	-485,000	-305,000	-425,000	-306,000	-284,000	-357,000	-188,000	-229,000	-93,000	-374,000	-308,000	-282,000	-250,000	-393,000	-297,000	-180,000
capitalized software development costs	-1,762,000	-1,446,000	-1,994,000	-1,652,000	-1,363,000					-867,000	-412,000	-1,106,000	-1,260,000	-1,302,000	-632,000	-399,000	-244,000
acquisition of business, net of cash acquired	0	-375,499,000								-500,000
net cash from investing activities	-2,947,000	-389,413,000	3,771,000	15,467,000	6,808,000	50,269,000	-16,262,000	-15,861,000	15,765,000	23,666,000	11,902,000	-145,955,000	-113,621,000	-1,552,000	-19,025,000	-696,000	-750,000
cash flows from financing activities:
payments on revolving loan
debt issuance costs paid	-1,119,000	-779,000				0	0			0	78,000
proceeds from espp issuances			0
proceeds from issuance of convertible senior notes	0	335,513,000
proceeds from borrowing under revolving loan	0	60,000,000
purchase of capped call transaction	0	-33,879,000
payments for taxes related to net settlement of equity awards			-25,000	-7,117,000	-5,678,000	-4,956,000	-4,204,000	-4,841,000	-1,984,000	-2,069,000
proceeds from stock option exercises	732,000	1,523,000	5,154,000	5,757,000	1,171,000	5,696,000	4,485,000	1,386,000	1,416,000	290,000	827,000	346,000	936,000	2,695,000	1,482,000	2,106,000	2,829,000
net cash from financing activities	-7,444,000	362,378,000	4,766,000	1,238,000	-4,507,000	-83,018,000	-781,000	-3,452,000	-568,000	-1,714,000	309,000	61,961,000	623,000	5,387,000	1,464,000	187,435,000	-2,013,000
net increase in cash and cash equivalents	-9,234,000	-32,699,000
cash and cash equivalents, beginning of period	0	94,359,000
cash and cash equivalents, end of period	-9,234,000	61,660,000
gain on financial instruments					-112,000
prepaid expenses and other current assets		-5,416,000	1,171,000	-2,157,000	-1,633,000		-749,000	772,000	-2,654,000		671,000	-3,301,000	-172,000		2,630,000	-2,112,000	-1,207,000
supplemental information and non-cash activities
accrued but unpaid debt issuance costs		1,119,000
amortization of debt issuance costs			96,000	33,000	32,000	28,000	30,000	35,000	45,000	40,000	83,000	19,000	10,000	11,000	13,000	13,000	13,000
gain on lease modification						0
principal payments on debt						-82,875,000	-1,062,000			0	0	-24,375,000	-313,000
payment of holdback funds from acquisition						-2,600,000	0
net increase in cash and cash equivalents and restricted cash			19,524,000	17,253,000	3,252,000				5,582,000	8,209,000	7,535,000			-8,322,000	-22,075,000
cash and cash equivalents and restricted cash, beginning of period			0	0	40,927,000	0	0	0	112,337,000	0	0	0	312,954,000		0	0	171,663,000
cash and cash equivalents and restricted cash, end of period			19,524,000	17,253,000	44,179,000	-38,054,000	-13,915,000	-25,023,000	117,919,000	8,209,000	7,535,000	-95,072,000	191,665,000		-22,075,000	176,403,000	166,948,000
gain from revaluation of contingent consideration
(gain) loss on financial instruments						-102,000	-253,000	33,000	-210,000
loss on extinguishment of debt
deferred implementation costs						-3,761,000	-1,103,000	-1,997,000	-859,000	-4,572,000	-2,433,000	-902,000	-469,000	-3,047,000	-561,000	-495,000	-556,000
deferred rent and tenant allowances											-178,000	-174,000	-173,000	-171,000	-164,000	-157,000	-76,000
proceeds from sales, maturities, and redemptions of marketable securities
proceeds from issuance of long-term debt										0	0
proceeds from exercise of warrants														0
proceeds from espp issuance						1,717,000	0			1,065,000	0
deferred ipo issuance costs paid														0	-663,000	-2,512,000	-1,345,000
repurchase of common stock														0	0	0	-3,497,000
proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions														0	0
payment of series b dividend														0	0
supplemental disclosure of cash flow information:
cash paid for interest
cash paid for taxes
gain on revaluation of contingent consideration										-12,800,000	0	0	-2,700,000
proceeds from maturities and redemptions of marketable securities							32,230,000	27,500,000	38,122,000	48,250,000	32,500,000
capitalized software development costs1							-1,182,000	-1,520,000	-1,141,000
net decrease in cash and cash equivalents and restricted cash							-13,915,000						-121,289,000
loss on financial instruments										-246,000	59,000	254,000	133,000		0	1,391,000	1,644,000
borrowings on line of credit
payments on line of credit
proceeds on sales of preferred stock, net of issuance costs
payments on capital lease obligations
purchase of common stock in tender offer
acquisition of business														0	-18,000,000	0	-326,000
supplemental disclosure of noncash financing activities
deferred ipo offering costs not yet paid																-1,459,000	2,122,000
cash, restricted cash, and cash equivalents, beginning of period
cash, restricted cash, and cash equivalents, end of period
supplemental disclosure of noncash investing and financing activities:
accrued property additions
net decrease in cash and cash equivalents																	-4,715,000

We provide you with 20 years of cash flow statements for Alkami Technology . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Alkami Technology . stock. Explore the full financial landscape of Alkami Technology . stock with our expertly curated income statements.

The information provided in this report about Alkami Technology . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.